Antipsychotic agents antagonize non-competitiveN-methyl-d-aspartate antagonist-induced behaviors

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Psychopharmacology

• Publication date

  1995-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF02246146PMID 7480537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of MK-801 response by dopaminergic agents in mice

  2005cited by this paper
• MK-801-induced stereotypy and its antagonism by neuroleptic drugs

  2005cited by this paper
• The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

  2005cited by this paper
• Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients

  2004cited by this paper
• Neuropharmacological studies of phencyclidine (PCP)-induced behavioral stimulation in mice

  2004cited by this paper
• Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens.

  1993cited by this paper
• Effects of atypical antipsychotic agents on social behavior in rodents.

  1993cited by this paper
• The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.

  1992cited by this paper
• Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.

  1992cited by this paper
• The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.

  1992cited by this paper
• Treatment of the neuroleptic-nonresponsive schizophrenic patient.

  1992cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• Molecular biology of the dopamine receptors.

  1991cited by this paper
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• Presynaptic Glutamate Receptors Modulate Dopamine Release from Striatal Synaptosomes

  1991cited by this paper
• Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics.

  1991cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

  1990cited by this paper
• In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other.

  1990cited by this paper
• A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

  1989cited by this paper
• The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.

  1989cited by this paper
• Do Negative Symptoms Respond to Pharmacological Treatment?

  1989cited by this paper
• Clozapine for the treatment-resistant schizophrenic: results of a US multicenter trial

  1989cited by this paper
• Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

  1989cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper
• Is it possible to model psychotic states in animals?

  1987cited by this paper
• Glycine potentiates N-methyl-D-aspartate-induced [3H]TCP binding to rat cortical membranes.

  1987cited by this paper
• The two-syndrome concept and neuroendocrinology of schizophrenia.

  1986cited by this paper
• Presynaptic dopaminergic modulation of cortical input to the striatum.

  1986cited by this paper
• Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.

  1985cited by this paper
• Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice.

  1984cited by this paper
• A social interaction model of anxiety sensitive to acutely administered benzodiazepines

  1984cited by this paper
• Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine.

  1983cited by this paper
• Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.

  1978cited by this paper
• Mesolimbic involvement with behavioural effects indicating antipsychotic activity.

  1974cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Preincubation with antipsychotic drugs protects against in vitro phencyclidine-mediated spontaneous neuronal network suppression.

  2025cites this paper
• Theta/gamma Co-modulation Disruption After NMDAr Blockade by MK-801 Is Associated with Spatial Working Memory Deficits in Mice

  2023cites this paper
• Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders

  2023cites this paper
• Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia

  2023cites this paper
• Behavioral features and disorganization of oscillatory activity in C57BL/6J mice after acute low dose MK-801 administration

  2022cites this paper
• Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis.

  2022cites this paper
• The α2C-adrenoceptor antagonist JP-1302 controls behavioral parameters, tyrosine hydroxylase activity and receptor expression in a rat model of ketamine-induced schizophrenia-like deficits.

  2022cites this paper
• Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders

  2022cites this paper
• Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease

  2021cites this paper
• Measuring sociability of mice using a novel three-chamber apparatus and algorithm of the LABORASTM system.

  2020cites this paper
• Atypical but not typical antipsychotic drugs ameliorate phencyclidine-induced emotional memory impairments in mice.

  2019cites this paper
• Evaluation of Antipsychotic Activity of Ethanolic Extract of Dhatryadi Ghrita on Wistar Rats

  2019cites this paper
• Top-Down Suppression of Sensory Cortex in an NMDAR Hypofunction Model of Psychosis

  2019cites this paper
• Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats

  2018cites this paper
• RGS4 deficit in prefrontal cortex contributes to the behaviors related to schizophrenia via system xc--mediated glutamatergic dysfunction in mice

  2018cites this paper
• Short‐ and long‐term behavioral analysis of social interaction, ultrasonic vocalizations and social motivation in a chronic phencyclidine model

  2017cites this paper
• Neuroanatomical Substrates of Rodent Social Behavior: The Medial Prefrontal Cortex and Its Projection Patterns

  2017cites this paper
• Dose‐response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia‐like symptom classes in rat

  2017cites this paper
• Phenotypes associated with psychiatric disorders are sex-specific in a mutant mouse line.

  2016cites this paper
• Prediction error, ketamine and psychosis: An updated model

  2016cites this paper
• Genetic association analysis of N‐methyl‐d‐aspartate receptor subunit gene GRIN2B and clinical response to clozapine

  2016cites this paper
• Differential Effects of Olanzapine and Haloperidol on MK-801-induced Memory Impairment in Mice

  2016cites this paper
• Glutamatergic agents for schizophrenia: current evidence and perspectives

  2015cites this paper
• Frontal lobe function and social adjustment in patients with schizophrenia: near‐infrared spectroscopy

  2015cites this paper
• Animal Models of Schizophrenia with a Focus on Models Targeting NMDA Receptors

  2015cites this paper
• Tests for Anxiolytic Activity

  2015cites this paper
• Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia.

  2015cites this paper
• Long-Term Treatment with Olanzapine in Hospital Conditions: Prevalence and Predictors of the Metabolic Syndrome.

  2015cites this paper
• MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol

  2015cites this paper
• Behavioral effects of phencyclidine on nicotine self-administration and reinstatement in the presence or absence of a visual stimulus in rats

  2015cites this paper
• Examining the reinforcement-enhancement effects of phencyclidine and its interactions with nicotine on lever-pressing for a visual stimulus

  2015cites this paper
• Effects of prefrontal cortex and hippocampal NMDA NR1-subunit deletion on complex cognitive and social behaviors.

  2015cites this paper
• Independent Effects of Paternal Age and Neuregulin1 Expression in Mice in Relation to Schizophrenia

  2014influential citation
• Diazepam improves aspects of social behaviour and neuron activation in NMDA receptor‐deficient mice

  2014cites this paper
• Oscillations dans la bande de fréquence gamma dans des modèles de rongeurs pour la schizophrénie

  2014cites this paper
• Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat

  2014cites this paper
• Ethanolic extracts of Alstonia Scholaris and Bacopa Monniera possess neuroleptic activity due to anti-dopaminergic effect

  2014influential citation
• The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

  2014cites this paper
• Gamma frequency oscillations in rodent models for schizophrenia

  2014cites this paper
• Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.

  2014cites this paper
• Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Irritability in Autistic Children

  2014cites this paper
• A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses

  2014cites this paper
• Developing zebrafish models of autism spectrum disorder (ASD).

  2014cites this paper
• Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice.

  2013cites this paper
• Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds.

  2013cites this paper
• The antipsychotic‐like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents

  2013cites this paper
• Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis.

  2013cites this paper
• CUSTO DOS ANTIPSICÓTICOS: A PARTICIPAÇÃO DO ESTADO E DA INICIATIVA PRIVADA

  2013cites this paper
• Psychopharmacological effects of acute exposure to kynurenic acid (KYNA) in zebrafish.

  2013cites this paper
• Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.

  2013cites this paper
• Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.

  2013cites this paper
• Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats

  2013cites this paper
• N-methyl-D-aspartate Receptors Are Involved in Caffeine-Induced Facilitation on Memory Retention of Passive Avoidance Learning in Rats

  2013cites this paper
• Design, Synthesis, and Pharmacological Evaluation of Novel Antipsychotic Drugs Based on Olanzapine That Display Reduced Weight Gain and Metabolic Side Effects

  2012cites this paper
• Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats

  2012cites this paper
• D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia.

  2012cites this paper
• The Glutamate Hypothesis of Schizophrenia Therapeutic Implications

  2012cites this paper
• Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia.

  2012cites this paper
• Direct and indirect interactions of the dopamine D3 receptor with glutamate pathways: implications for the treatment of schizophrenia

  2012cites this paper
• Comparative extrapyramidal effects of Rauwolfia vomitoria, chlorpromazine and reserpine in mice

  2012cites this paper
• Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.

  2011cites this paper
• Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol

  2011cites this paper
• Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatment.

  2011cites this paper
• Interaction between genetic variants of DLGAP3 and SLC1A1 Affecting the Risk of Atypical Antipsychotics‐Induced Obsessive–Compulsive Symptoms

  2011cites this paper
• Expression of parvalbumin and glutamic acid decarboxylase-67 after acute administration of MK-801. Implications for the NMDA hypofunction model of schizophrenia

  2011cites this paper
• The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment

  2011cites this paper
• Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.

  2011cites this paper
• Caractérisations biochimique anatomique et comportementale des souris dépourvues de la protéines STOP : un modèle expérimental pour l'étude de symptômes psycho-affectifs

  2011cites this paper
• Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain

  2011cites this paper
• Disinhibition of Prefrontal Cortex Neurons in Schizophrenia

  2010cites this paper
• Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio).

  2010cites this paper
• Current pharmacological models of social withdrawal in rats: relevance to schizophrenia

  2010influential citation
• Norzotepine, a Major Metabolite of Zotepine, Exerts Atypical Antipsychotic-Like and Antidepressant-Like Actions through Its Potent Inhibition of Norepinephrine Reuptake

  2010cites this paper
• The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine.

  2010cites this paper
• Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics

  2010cites this paper
• Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity.

  2010cites this paper
• MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction

  2009cites this paper
• Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs.

  2009cites this paper
• Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice.

  2009cites this paper
• Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity.

  2009cites this paper
• Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents.

  2009cites this paper
• Cognitive Effects of Second-Generation Antipsychotics

  2009cites this paper
• Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

  2008cites this paper
• Effects of nicotine on quinpirole- and dizocilpine (MK-801)-induced sensorimotor gating impairments in rats

  2008cites this paper
• Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584.

  2008cites this paper
• Cannabinoid and neuregulin 1 gene interaction as an animal model of increased vulnerability to schizophrenia

  2008cites this paper
• Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.

  2008cites this paper
• Influenza A Virus Infection and NMDA receptor function

  2008cites this paper
• Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.

  2008cites this paper
• Influenza A virus infection and NMDA receptor function : A behavioral and molecular study of relevance for schizophrenia

  2008cites this paper
• Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine

  2008cites this paper
• Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia.

  2008cites this paper
• Differential Effects of Antipsychotic and Glutamatergic Agents on the phMRI Response to Phencyclidine

  2008cites this paper
• Activities of the Antipsychotic Drugs Haloperidol and Risperidone on Behavioural Effects Induced by Ketamine in Mice

  2008cites this paper
• The prefrontal cortex and information processing : nitric oxide signaling studied in an animal model of schizophrenia

  2008cites this paper
• The Selective mGlu5 Receptor Antagonist MTEP, Similar to NMDA Receptor Antagonists, Induces Social Isolation in Rats

  2007cites this paper
• Effects of behavioral and neurochemical changes on adult excitotoxic lesion of the ventral hippocampus.

  2007cites this paper
• Molecular targets for treating cognitive dysfunction in schizophrenia.

  2007cites this paper
• Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic

  2007cites this paper
• Memantine-associated Reversal of Clozapine-induced Weight Gain

  2007cites this paper